Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
430 - One of the pivotal trials for an advertised brand has a reference comparator (RC) arm (i.e., the trial has statistical analysis for the advertised brand vs placebo and the RC vs placebo, but no statistical analysis for the advertised brand vs RC). The Product Monograph mentions the RC as part of the design, but no RC data is included in the PM. Can the data for the RC vs placebo be shown in an APS?
-
No. An APS presentation conveying how the sponsor’s drug compares to a reference comparator would not meet the evidentiary requirements of the PAAB code (i.e. a rigorously designed study with pre-planned inferential statistical significance analysis directly comparing the two active products). Note however that the RC data could be considered in cases where the PM contains the RC data (rather than the only mention of the RC being in the study description). In such cases, the data presentation should reflect the context and emphasis of the product monograph.
